
Join to view full profile
1021 Morehead Medical DrSte ACharlotte, NC 28204
Phone+1 980-442-2000
Fax+1 704-355-5800
Dr. Frenette is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1992 - 1996
Duke University HospitalResidency, Internal Medicine, 1990 - 1992
University of Michigan Medical SchoolClass of 1990
Certifications & Licensure
NC State Medical License 1996 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, Cerner Patient Portal, HealthSentry and P2 Sentinel, Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification MEDSEEK Empower, SymphonyCare, LLC, 2014
Clinical Trials
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 10 citationsA phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R Antonescu
Cancer. 2024-03-01 - 50 citationsMolecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot studyJoel J. Napeñas, Michael T. Brennan, Shirley Coleman, M. Louise Kent, Jenene Noll
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2010-04-01 - 73 citationsPhase II assessment of talabostat and cisplatin in second-line stage IV melanomaRobert M Eager, Casey Cunningham, Neil Senzer, Joe Stephenson, Stephen P. Anthony
BMC Cancer. 2009-07-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: